diabetic kidney disease

Victoria SochaKidney Transplantation | February 5, 2024
The most common primary renal disease in patients initiating renal replacement therapy is diabetes.
Read More
Victoria SochaDiabetes and Hypertension | February 5, 2024
Several classes of glucose-lowering drugs have been shown to have kidney benefits in patients with type 2 diabetes.
Victoria SochaDiabetes and Hypertension | February 5, 2024
The most common concomitant medication classes were antihypertensives (95%), antihyperglycemic (81%), and statins (79%).
Victoria SochaDiabetes and Hypertension | February 5, 2024
Preliminary evidence has demonstrated preservation of kidney function as measured by eGFR compared with baseline.
Victoria SochaHyperkalemia | February 5, 2024
There was a five-fold higher risk of hyperkalemia with use of a steroidal MRA plus an ACEi or ARB.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Assessing the early impact of risk categorization on management of patients with DKD.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Gaps in care in treating proteinuria in patients with DKD.
Victoria SochaNephrology Times | February 5, 2024
In the population of patients with chronic kidney disease (CKD), particularly those with diabetes as the underlying ...
Victoria SochaDiabetes and Hypertension | February 5, 2024
In patients with type 2 diabetes, ectopic fat is a major pathogenic factor. According to Niels Sondergaard Heinrich, MD, ...
Victoria SochaDiabetes and Hypertension | February 5, 2024
Nonalbuminuric diabetic kidney disease (DKD) has become the prevailing phenotype of DKD. Qiao Jin, MSc, and colleagues, ...
Victoria SochaChronic Kidney Disease | February 5, 2024
According to Mukoso N. Ozieh, MD, and Leonard E. Egede, MD, MS, of the Medical College of Wisconsin, behavioral factors, ...
Victoria SochaNational Kidney Foundation 2022 | February 5, 2024
FIDELITY, a prespecified pooled analysis of results from the phase 3 FIDELIO-DKD and FIGARO-DKD trials, demonstrated ...
Victoria SochaChronic Kidney Disease | February 5, 2024
Patient education is a component of prevention of progression of kidney disease. Paul Flynn and colleagues at SUNY ...
Victoria SochaDiabetes and Hypertension | February 5, 2024
Clinical trials in nephrology are enriched for patients with micro- or macroalbuminuria to enroll patients at risk of ...
Victoria SochaDiabetes and Hypertension | February 5, 2024
Among obese patients with type 2 diabetes, hyperfiltration is a risk factor for accelerated decline in glomerular ...
Victoria SochaDiabetes and Hypertension | February 5, 2024
Worldwide, the prevalence of end-stage kidney disease (ESKD) is increasing; the leading cause of ESKD is diabetes. The ...
Victoria SochaDiabetes and Hypertension | February 5, 2024
Approximately 30.3 million individuals in the United States are affected by diabetes; since the 1980s, there has been a ...
Victoria SochaDiabetes and Hypertension | June 23, 2021
The diagnosis of diabetes can be done using retinopathy to determine the diagnostic glucose or hemoglobin A1c (HbA1c) ...
Victoria SochaDiabetes and Hypertension | May 21, 2021
Approximately 40% of patients with diabetes develop diabetic kidney disease, the most common cause of chronic kidney ...
Advertisement
Advertisement
Latest News

February 27, 2024